| JP08066453 | AUTOMATIC FOOT WASHER |
| JP2006089474 | HERBACEOUS MATERIAL-FERMENTING BATH |
| JP2010104532 | HEATING RELAXATION SYSTEM |
SHKOLNYY, Vladimir Nikolaevich (ul. Nezhnova 67-1-16, PyatigorskStavroposlkii Region, 35760, RU)
MAYDAN, Ivan Alexandrovich (ul. Michurina, 15Stanitsa Essentukskaya,Predgornyi distric, Stavropolskii Region 4, 35761, RU)
SHKOLNYY, Viacheslav Vladimirovich (ul. Nezhnova 67-1-16, PyatigorskStavroposlkii Region, 35760, RU)
BOYAKOVA, Irina Grigor'evna (Goryachevodsky Settlement, 57Pyatigors, Stavropolskii Region 2, 35760, RU)
SHKOLNYY, Vladimir Nikolaevich (ul. Nezhnova 67-1-16, PyatigorskStavroposlkii Region, 35760, RU)
MAYDAN, Ivan Alexandrovich (ul. Michurina, 15Stanitsa Essentukskaya,Predgornyi distric, Stavropolskii Region 4, 35761, RU)
SHKOLNYY, Viacheslav Vladimirovich (ul. Nezhnova 67-1-16, PyatigorskStavroposlkii Region, 35760, RU)
BOYAKOVA, Irina Grigor'evna (Goryachevodsky Settlement, 57Pyatigors, Stavropolskii Region 2, 35760, RU)
| What is claimed is a 1. Mud applicator that can be used in combination with electrotherapy and magnetotherapy and suitable for prophylactic and cosmetic procedures said applicator comprising peloids packaged in an unwoven and/or light and gas impermeable enclosure wherein said peloids comprise max. 0.5 mm sized particles, said enclosure is made from unwoven thermally bonded material with a surface density of 5 to 100 g/m by bonding the edges of said unwoven thermally bonded cloth providing for a cohesion strength of at least 0.1 N/cm2 and/or from 10 to 150 μιη thick laminated metal coated polymer film having a light and gas impermeable layer. 2. Applicator of Claim 1 wherein peloids are used. 3. Applicator of Claim 1 wherein said peloids contain max. 0.3 mm sized particles. 4. Applicator of Claim 1 wherein said primary enclosure is made from unwoven thermally bonded material with a surface density of 10 to 75 g/m2. 5. Applicator of Claim 1 wherein said primary enclosure is made from unwoven thermally bonded material comprising at least polyester fibers and/or viscose fibers and/or polypropylene fibers. 6. Applicator of Claim 5 wherein unwoven thermally bonded cloth is used comprising both polyester, viscose and polypropylene fibers, and their combinations. 7. Applicator of Claim 1 wherein said enclosure is made from unwoven thermally bonded material the edges of which are bonded with glue based on an ethylene and vinyl acetate copolymer with an adhesive capacity of at least 0.3 N/cm . 8. Applicator of Claim 1 wherein said enclosure is made from unwoven thermally bonded material by thermally bonding its edges. 9. Applicator of Claim 1 wherein said applicator can be used in combination with electrotherapy and magnetotherapy. |
This invention relates to medicine, more specifically, to mud therapy, and can be used, inter alia, in combination with electrotherapy, magnetotherapy, prophylactic and cosmetic procedures.
Peloids are natural formations consisting of the following interconnected components: mud solution (the fluid fraction), coarse grained fraction (the skeleton) and fine grained fraction (the colloidal complex). Peloids as a natural factor have an explicit therapeutic effect due to their physicochemical properties.
Experiments have shown that an important precondition for mud therapy is to preserve the natural composition of peloids while converting them to a shape that is required and suitable for mud therapy procedures. This result is normally achieved by placing peloids into special enclosures (containers). The material of said enclosures (containers) suitable for preserving the therapeutic properties of peloids must possess a sufficient scope of characteristics excluding the contact of peloids with the ambience (air, light etc.). The enclosure material providing for a suitable shape of peloids must also possess properties providing for the required contact between the patient's body and peloid components, withstand the weight of peloids even in wet condition and allow combining mud therapy with electrotherapy and magnetotherapy. Known is (RU Patent 2161947) a container comprising an enclosure which in turn contains peloid for application to the patient's body. Said container is made from elastic polymer in the form of a plate the thickness of which is equal to the thickness of the layer being applied wherein said plate comprises a system of open end channels. The peloid is contained in said system of open end channels.
A disadvantage of the known container (applicator) is the complex procedure of its filling with peloid and the inefficient transfer of biologically active peolid components to the patient's body.
Known is (DE Patent 3221647) a container for limb mud therapy comprising a case with an enclosure for peloid and a heat release reducing device installed on the open portion of said case wherein the cavity between the case walls and said enclosure is filled with the working media maintaining the required temperature of the peloid.
A disadvantage of the known container (applicator) is the narrow application range and the inefficient transfer of biologically active peolid components to the patient's body.
Known is (RU Patent 2006219) a container for limb mud therapy comprising a case with an enclosure for peloid and a heat release reducing device installed on the open portion of said case wherein the cavity between the case walls and said enclosure is filled with the working media maintaining the required temperature of the peloid, further wherein said case and said enclosure are rigid and have shapes similar to the shape of the limb, said heat release reducing device is in the form of an elastic diaphragm, said case has a valve and said working media is vacuum. Preferably, said case and said enclosure and connected with stiffeners.
A disadvantage of the known container (applicator) is the narrow application range and the inefficient transfer of biologically active peolid components to the patient's body.
Known is (RU Patent 2245129) is a mud applicator comprising an enclosure filled with peloid. Further said applicator has a head, a backstop, a socket screwed into the threaded portion of the rear part, two electrodes one of which is installed in the head cavity and the other in the rear part cavity, an electric wire in the case cavity at the longitudinal axis one end of which is connected to the head electrode and the other is connected to one of the socket terminals, a wire connecting the rear part electrode to the second socket terminal and an electric cord with a plug for connecting said socket to mains wherein said electrodes are installed opposite each other and said electric cord is enclosed in a nonconductive pipe sheath.
A disadvantage of the known applicator is the narrow application range and the inefficient transfer of biologically active peolid components to the patient's body.
Known is (DE Patent 264928) is a mud therapy applicator comprising a fabric bag for peloid and a device for maintaining peloid temperature throughout the procedure.
A disadvantage of the known applicator is the inefficient transfer of biologically active peolid components to the patient's body. It has been found (RU Patent 2306942) that silt/clay deposits (peloids) prepared for use should be preferably packed in unwoven enclosure. However, far not all unwoven materials can be used for silt/clay deposits packaging.
The object of this technical solution is to improve the design of mud applicator to provide for a simpler application technology due to a higher mechanical strength combined with a higher efficiency of peloid component therapy.
The mud applicator provided herein comprises peloids packaged in an unwoven and/or light or gas impermeable enclosure wherein said peloids comprise max. 0.5 mm sized particles, said enclosure is made from unwoven thermally bonded material with a surface density of 5 to 100 g/m by bonding the edges of said unwoven thermally bonded cloth providing for a cohesion strength of at least 0.1 N/cm and/or from 2 to 150 μηι thick laminated metal coated polymer film having a light and gas impermeable layer.
When designing the mud applicator technology we found that peloids produced at different fields have close physicochemical parameters e.g. density, moisture content, acidity etc. which affect the applicator enclosure material. Therefore peoloids can be packaged in similar containers and enclosures regardless of their field of origin. When selecting container and enclosure material of the variety of unwoven materials known at the time of the research we found that, in order to provide for an efficient contact between the peloids and the patient's body, said material must have a surface density of 5 to 100 g/m regardless of mud therapy setup. This surface density range ensures sufficient applicator enclosure strength after filling with wet peloids and during applicator transportation and application while providing for maximally efficient mud therapy for the patient. As the unwoven primary enclosure material is a cloth, to form an applicator enclosure of the desired shape one should bond the cloth edges. Research showed that regardless of bonding method the cohesion strength of the joint must be at least 0.1 N/cm , otherwise the joint may fail when exposed to the weight of the peloids filling the enclosure.
Preferably, peloids should be used cleaned from foreign impurities and homogenized (refined and ground). Such peloids are known for their therapeutic properties and have for a long time been used in mud therapy. Although homogenization (refining and grinding) of peloids to a particle size of within 0.5 mm provides for an active material, it is preferred to homogenize (refine and grind) peloids to a particle size of within 0.3 mm or smaller. Although the unwoven material surface density range from 5 to 100 g/m provides for a good performance of the mud applicator enclosure, it is nevertheless preferable that large sized (and large weight) applicators are made with unwoven thermally bonded material having a surface density of 10 to 75 g/m .
It is preferable to use unwoven materials made from artificial and synthetic fibers. For instance, the enclosure can be made from unwoven thermally bonded material comprising at least polyester fibers and/or viscose fibers and/or polypropylene fibers. In the most preferable but not exclusive embodiment, unwoven thermally bonded cloth can be used comprising polyester, viscose and polypropylene fibers and their combinations. The edges of the mud applicator enclosure can be bonded using any method known from the background preventing peloid leaking from the enclosure. For example, enclosure edges can be bonded with glue preferably based on an ethylene and vinyl acetate copolymer with an adhesive capacity of at least 0.3 N/cm , or by thermal bonding of its edges to provide said adhesion strength.
Alternatively, peloids can be stored and transported in enclosures made from polymer (preferably polyethylene or polypropylene) films coated with a layer of light and gas impermeable material. This package is mainly used for the transportation of refmed mud as well as for vaginal mud therapy and in cosmetic applications. The film is preferably 20- 150 μπι thick. If used in this embodiment, this package is a thermally bonded bag with an adhesion strength of at least 0.1 N/cm .
Homogenization (refining and grinding) is preferably achieved in mills with a preset millstone gap size. However, other embodiments are possible. Preferably, enclosures of this type are filled with 0.005 to 50 dm 3 of homogenized (refined and ground) peloids.
In the preferred embodiment the mud applicator is manufactured as follows.
Peloids produced using any known method are mechanically cleaned from contaminants (plant debris, stones, man-made objects etc.). This can be achieved by either manual removal of contaminants or with a system of sieves with a preset mesh size. Said contaminants have no therapeutic effect and hinder further homogenization (refining and grinding). After contaminant removal the mud is crushed preferably with a screw crusher to refine the natural mechanical inclusions in the peloids. Other types of crushers can also be used for the processing of peloids.
Said natural mechanical inclusions can be, for instance, algae debris, crustacean shells, salt crystals, sand etc..
Peloids containing crushed natural mechanical inclusions are fed to an attrition mill for homogenization (refining) (homogenizers (refiners) of any type can be used providing for a final peloid particle size of about 0.3 mm). The preset clearance between the millstones provides for the required size of peloid particles.
Homogenized (refined) peloids are placed in containers and enclosures with characteristics corresponding to those claimed herein.
After an applicator enclosure or an enclosure-free applicator is filled with homogenized (refined) peloids, the peloid surface should be protected from ambience exposure. For this purpose, a filled applicator enclosure or an enclosure-free applicator is placed in an additional light and gas impermeable enclosure or container (e.g. aluminum foil laminated polymer films).
Experiments have shown that the use of peloids homogenized (refined) to a particle size of within 0.5 mm with crushed large mechanical inclusions greatly increases the therapeutic efficiency of the procedure due to a greater contact area between the active substances and the patient's skin or mucous.
The essence and advantages of the applicator technology designed herein will be disclosed below with specific application examples. Experiments have been conducted with 34 voluntary patients having different locomotorium diseases.
Example 1. Patient I., 42. Diagnosis: slowly proliferating polyarthritis, complaints: pain in knee, elbow and right hand joints and morning stiffness. Has been suffering for about 9 years starting from intumescence in the left knee joint accompanied with fever. Remission was achieved after therapy. Exacerbation in 2 years involved both the knee and ankle joints, and no remission was achieved in spite of therapy.
The patient received mud applications using applicators designed herein with homogenized (refined) peloids to both knee and elbow joints and the right hand. The peloid preheating temperature was 38-39°C, exposure 15 min once in two days, with a total of 10 procedures. The patient tolerated the procedures well, the joint pain and stiffness were relieved, the proliferating changes in the ankle and left knee joints reduced, and joint mobility improved.
Thus, the therapy course led to a positive clinical result, including in the exudation inflammation joint, the activity of the inflammatory and immune affecting processes decreased, and the electrocardiogram improved.
Therapy of patients using applicators known from the prototype solution had lower efficiency especially where joints had exudation inflammation, cardiovascular pathology and immune disorders. Below is one of observations.
Example 2. Patient P., 24. Diagnosis: slowly proliferating seronegative oligoarthritis. Complaints: pain joints, morning stiffness for 30 min and restricted arm and leg joint mobility. Has been suffering for 4 years starting from tonsillitis accompanied with fever and knee joint intumescence. Exacerbation in 1 year involved the ankle and small hand and wrist joints. Received prednisolone. Large arm and leg joint contractures developed. Admission diagnosis: contractures of all large joints (except shoulder and wrist ones) with predominant proliferative fibrous changes, and local fever (1 point) above the right knee joint.
The patient received therapy using mud applicators at knee and ankle joints at 38-39 °C for 15 min once in two days with a total of 10 procedures followed by additional joint massage. The patient tolerated the procedures well, the joint pain reduced, the morning stiffness became less acute, the joint mobility improved. However, the temperature above the right knee joint increased by 0.8 °C, and palpatory tenderness at the joint increased.
Thus, subjectively, the patient's condition improved, but exudation effects in the joint became more explicit, disease activity increased, the electrocardiogram worsened, and the immune status did not change.
Therapy following the suggested method (6 procedures) was given to 16 patients with different forms of arthritis (main group), while the reference group (10 procedures using the prototype) included 18 patients. The groups were representative by sex, age, disease duration and severity.
Therapy using applicators designed herein was successful in 13 main group patients, 2 patients felt slight improvement, and 1 patient had no change in status. For the reference group, therapy was successful in 12 patients, 4 patients felt improvement, and 2 patients had no change in status.
Similar studies gave comparable results for gynecological, urological and oral cavity diseases.
Thus, the use of mud applicators designed herein increases the efficiency of therapy. Presumably, the active particles penetrating to skin through the enclosure remain on the patient's body for a longer time also leading to a more efficient therapy. Also, experiments have shown that the use of additional light and gas impermeable enclosures further increases the efficiency of therapy due to the preservation of curing components of peloids as a result of heating and during mud storage.
Next Patent: REINFORCEMENT CABLE